2022
DOI: 10.1016/j.molliq.2021.117028
|View full text |Cite
|
Sign up to set email alerts
|

Pluronic F127/Doxorubicin microemulsions: Preparation, characterization, and toxicity evaluations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 40 publications
(13 citation statements)
references
References 68 publications
1
12
0
Order By: Relevance
“…In general, high pH sensitivity is characteristic of the release rate of doxorubicin bound to the carrier through electrostatic interactions [ 62 , 63 ]. The time it takes to reach equilibrium release of electrostatically immobilized doxorubicin by an amphiphilic copolymer of N-vinyl-2-pyrrolidone and acrylic acid is close to that determined in works [ 21 , 22 , 63 ] when gold nanoparticles stabilized with pectin (galacturonic acid) [ 63 ] or microemulsions were used as carriers [ 21 , 22 ]. The application of a pegylated copolymer of lactic and glycolic acids described in [ 37 ] makes it possible to increase the time to reach the equilibrium release of doxorubicin, but it is complicated by a pulsed release of about 20% of the drug at the initial time.…”
Section: Resultssupporting
confidence: 76%
See 1 more Smart Citation
“…In general, high pH sensitivity is characteristic of the release rate of doxorubicin bound to the carrier through electrostatic interactions [ 62 , 63 ]. The time it takes to reach equilibrium release of electrostatically immobilized doxorubicin by an amphiphilic copolymer of N-vinyl-2-pyrrolidone and acrylic acid is close to that determined in works [ 21 , 22 , 63 ] when gold nanoparticles stabilized with pectin (galacturonic acid) [ 63 ] or microemulsions were used as carriers [ 21 , 22 ]. The application of a pegylated copolymer of lactic and glycolic acids described in [ 37 ] makes it possible to increase the time to reach the equilibrium release of doxorubicin, but it is complicated by a pulsed release of about 20% of the drug at the initial time.…”
Section: Resultssupporting
confidence: 76%
“…Rapidly advancing nanomedicine methods make it possible to reduce the cardiac toxicity of doxorubicin by incorporating it into nanoscale aggregates and providing delivery targeting. Nanoparticles of gold [ 16 ], iron oxide [ 17 ], magnesium aluminum layered double hydroxides [ 18 , 19 ], lipids [ 20 ] and oil-in-water microemulsions [ 21 , 22 ] are promising as carriers for doxorubicin loading. Conjugates with biological molecules, such as human serum albumin (HSA), bovine serum albumin (BSA), milk beta-lactoglobulin (β-LG) [ 23 ], apoferritin [ 24 ] and glycosaminoglycans, as well as platelets [ 25 ], have also been studied as potential doxorubicin carriers.…”
Section: Introductionmentioning
confidence: 99%
“…This highest antibacterial activity may be due to the intrinsic characteristics of MNPs and starch into MNPs and the synergistic effects observed in the presence of AgNPs. [ 25,74,75 ]…”
Section: Resultsmentioning
confidence: 99%
“…This highest antibacterial activity may be due to the intrinsic characteristics of MNPs and starch into MNPs and the synergistic effects observed in the presence of AgNPs. [25,74,75] It is evident that the overall antibacterial performance is related to the synergistic effect of each component in the nanocomposite having an antibacterial effect. As can be seen from Figure 10A,B, it is clear that, with further increase of Ag concentrations in nanocomposites (MNPs@Starch-Ag/PU-b nanocomposite (8b) and MNPs@Starch-Ag/PU-c nanocomposite (8c)), the inhibition zones not only did not increase but rather decreased; this may be related to AgNP agglomeration in higher concentrations of AgNPs in the nanocomposites which reduced the antibacterial effect.…”
Section: Antibacterial Activitymentioning
confidence: 99%
“…This system is thus particularly interesting given the possible applications in many fields. In particular, it is one of the most widely used triblock copolymers in pharmaceutical formulations because of the good water solubility through the high content of EO, the low toxicity in the body and the ability to encapsulate any hydrophobic agents [ 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 ]. However, it is well known that the addition of co-solvents or solutes to pluronic water solutions can influence its properties, inducing phase changes [ 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 ].…”
Section: Introductionmentioning
confidence: 99%